Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy.

Mutations of the common gamma chain (gammac) of cytokine receptors cause X-linked severe combined immunodeficiency (XSCID), a candidate disease for gene therapy. Using an XSCID murine model, we have tested the feasibility of stem cell gene correction. XSCID bone marrow (BM) cells were transduced with a retroviral vector expressing the murine gammac (mgammac) and engrafted in irradiated XSCID animals. Transplanted mice developed mature B cells, naive T cells, and mature natural killer (NK) cells, all of which were virtually absent in untreated mice. The mgammac transgene was detected in all treated mice, and we could demonstrate mgammac expression in newly developed lymphocytes at both the RNA and protein level. In addition, treated mice showed T cell proliferation responses to mitogens and production of antigen-specific antibodies upon immunization. Four of seven treated animals showed a clear increase of the transgene positive cells, suggesting in vivo selective advantage for gene-corrected cells. Altogether, these results show that retroviral-mediated gene transfer can improve murine XSCID and suggest that similar strategies may prove beneficial in human clinical trials.

• Publication year

  2000

• Venue

  Molecular Therapy

• Publication date

  2000-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/MTHE.1999.0020PMID 10933924
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• lnterleukin-2 Receptor y Chain Mutation Results in X-Linked Severe Combined Immunodeficiency in Humans

  2008cited by this paper
• Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach.

  1999cited by this paper
• Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

  1999cited by this paper
• Pim1 Reconstitutes Thymus Cellularity in Interleukin 7–And Common γ Chain–Mutant Mice and Permits Thymocyte Maturation in Rag- but Not Cd3γ-Deficient Mice

  1999cited by this paper
• gammac gene transfer in the presence of stem cell factor, FLT-3L, interleukin-7 (IL-7), IL-1, and IL-15 cytokines restores T-cell differentiation from gammac(-) X-linked severe combined immunodeficiency hematopoietic progenitor cells in murine fetal thymic organ cultures.

  1998cited by this paper
• Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.

  1998cited by this paper
• Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice

  1998cited by this paper
• T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates

  1998cited by this paper
• Restoration of lymphocyte function in Janus Kinase 3-deficient mice by retroviral-mediated gene transfer

  1998cited by this paper
• Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells.

  1998cited by this paper
• γc Gene Transfer in the Presence of Stem Cell Factor, FLT-3L, Interleukin-7 (IL-7), IL-1, and IL-15 Cytokines Restores T-Cell Differentiation From γc(−) X-Linked Severe Combined Immunodeficiency Hematopoietic Progenitor Cells in Murine Fetal Thymic Organ Cultures

  1998cited by this paper
• Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease.

  1997cited by this paper
• Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants.

  1997cited by this paper
• Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease.

  1997cited by this paper
• Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease.

  1997cited by this paper
• Interleukin-7R alpha mRNA expression increases as stem cells differentiate into T and B lymphocyte progenitors.

  1997cited by this paper
• Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells.

  1996cited by this paper
• Retroviral-mediated gene correction for X-linked severe combined immunodeficiency.

  1996cited by this paper
• In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction

  1996cited by this paper
• Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the gamma-c gene.

  1996cited by this paper
• gamma-c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function.

  1996cited by this paper
• Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain.

  1996cited by this paper
• Role of the Common Cytokine Receptor γ Chain in Cytokine Signaling and Lymphoid Development

  1995cited by this paper
• Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.

  1995cited by this paper
• Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.

  1995cited by this paper
• T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years

  1995cited by this paper
• Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells

  1995cited by this paper
• Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA− Immunodeficient Patients

  1995cited by this paper
• Signal transduction mediated by the reconstituted IL-2 receptor. Evidence for a cell type-specific function of IL-2 receptor beta-chain.

  1994cited by this paper
• Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method.

  1994cited by this paper
• Cloning of the mouse interleukin 2 receptor gamma chain: demonstration of functional differences between the mouse and human receptors.

  1993cited by this paper
• Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency.

  1993cited by this paper
• The IL-2/IL-2 receptor system: a current overview.

  1993cited by this paper
• The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.

  1993cited by this paper
• Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1.

  1992cited by this paper
• Construction and use of a safe and efficient amphotropic packaging cell line.

  1988cited by this paper
• Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.

  1988cited by this paper
• Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

  1986cited by this paper

• Evaluating the state of the science for adeno-associated virus integration: An integrated perspective

  2022cites this paper
• Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia

  2018cites this paper
• Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice.

  2018cites this paper
• The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors

  2016cites this paper
• Gene therapy for primary immunodeficiencies

  2015cites this paper
• How Primary Immunodeficiencies Have Made Gene Therapy a Reality

  2014cites this paper
• Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases

  2014cites this paper
• Severe Combined Immunodeficiencies

  2014cites this paper
• Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

  2013cites this paper
• mice following gene transfer into bone marrow cells deficient - Reconstitution of lymphoid development and function in ZAP-70

  2013cites this paper
• Mouse Transplant Models for Evaluating the Oncogenic Risk of a Self-Inactivating XSCID Lentiviral Vector

  2013cites this paper
• Gene Therapy in Infants with Severe Combined Immunodeficiency

  2012cites this paper
• This information is current as Development Domain 1 Is Essential for Lymphocyte Transcription Factor Zinc Finger and BTB

  2012cites this paper
• Correction of SCID-X1 Using an Enhancerless Vav Promoter

  2011cites this paper
• Implications for Gene Therapy-Limiting Expression of IL-2Rγc Delineate Differences in Signaling Thresholds Required for Lymphocyte Development and Maintenance

  2010cites this paper
• A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells.

  2010cites this paper
• Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells.

  2009cites this paper
• Development of gene therapy for blood disorders.

  2008cites this paper
• Investigation of the therapeutic potential of transgenic CD40 ligand expression

  2007cites this paper
• Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells

  2007cites this paper
• Gene therapy: X-SCID transgene leukaemogenicity

  2006cites this paper
• Gene therapy: Therapeutic gene causing lymphoma

  2006cites this paper
• Gene therapy for primary immunodeficiency diseases: recent progress and misgivings.

  2006cites this paper
• Gene therapy: Is IL2RG oncogenic in T-cell development?: X-SCID transgene leukaemogenicity (reply)

  2006cites this paper
• Adult Stem Cells and Gene Therapy

  2006cites this paper
• Gene and Cell Therapy Involving Hematopoietic Stem Cell

  2006cites this paper
• Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy.

  2006cites this paper
• Genotoxicity of retroviral integration in hematopoietic cells.

  2006cites this paper
• In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer.

  2005cites this paper
• Severe combined immunodeficiency. A model disease for molecular immunology and therapy

  2005cites this paper
• T-cell signalling and immune system disorders

  2005cites this paper
• Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs

  2005cites this paper
• Gene therapy for severe combined immunodeficiency.

  2005cites this paper
• Aptamers: an emerging class of therapeutics.

  2005cites this paper
• Molecular basis of immunodeficiency

  2005cites this paper
• Molecular mechanisms in allergy and clinical immunology

  2005cites this paper
• Gene therapy for immunodeficiency diseases.

  2004cites this paper
• Jak3 and the pathogenesis of severe combined immunodeficiency.

  2004cites this paper
• Retroviral-mediated gene transfer restores IL-12 and IL-23 signaling pathways in T cells from IL-12 receptor beta1-deficient patients.

  2004cites this paper
• Safety concerns related to hematopoietic stem cell gene transfer using retroviral vectors.

  2004cites this paper
• Successes and risks of gene therapy in primary immunodeficiencies.

  2004cites this paper
• Stem cell clonality and genotoxicity in hematopoietic cells: gene activation side effects should be avoidable.

  2004cites this paper
• Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system.

  2004cites this paper
• Prolonged multilineage clonal hematopoiesis in a rhesus recipient of CD34 positive cells marked with a RD114 pseudotyped oncoretroviral vector.

  2003cites this paper
• Chance or necessity? Insertional mutagenesis in gene therapy and its consequences.

  2003cites this paper
• Lymphold reconstitution in X-linked severe combined immunodeficient mice by retrovirus-mediated gene transfer

  2002cites this paper
• Use of Adeno-Associated Virus in the Treatment of Cystic Fibrosis

  2002cites this paper
• Gene therapy for human severe combined immunodeficiencies.

  2002cites this paper
• Gene therapy of severe combined immunodeficiencies

  2002cites this paper
• Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.

  2002cites this paper
• Flow Cytometry Analysis of Adenosine Deaminase (ADA) Expression: A Simple and Reliable Tool for the Assessment of ADA-Deficient Patients Before and After Gene Therapy

  2002cites this paper
• Reconstitution of lymphoid development and function in ZAP-70-deficient mice following gene transfer into bone marrow cells.

  2002cites this paper
• Lack of dominant-negative effects of a truncated gamma(c) on retroviral-mediated gene correction of immunodeficient mice.

  2001cites this paper
• Gene therapy for primary immune deficiencies

  2001cites this paper
• Gene therapy for human severe combined immunodeficiencies.

  2001cites this paper
• Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.

  2001cites this paper
• Correction of genetic blood defects by gene transfer

  2001cites this paper
• Gene therapy for immunodeficiency

  2001cites this paper
• Self-Selection by Genetically Modified Committed Lymphocyte Precursors Reverses the Phenotype of JAK3-Deficient Mice without Myeloablation

  2000cites this paper
• Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency.Defects of the gc‐JAK3 signaling pathway as a model

  2000cites this paper
• Gene therapy of lymphoid primary immunodeficiencies

  2000cites this paper
• In Vivo Competitive Studies between Normal and Common γ Chain-Defective Bone Marrow Cells: Implications for Gene Therapy

  2000influential citation
• The potential for therapy of immune disorders with gene therapy.

  2000cites this paper